| Literature DB >> 34731048 |
Diana X Sahonero-Canavesi1, Laura Villanueva1,2, Nicole J Bale1, Jade Bosviel1, Michel Koenen1, Ellen C Hopmans1, Jaap S Sinninghe Damsté1,2.
Abstract
Membrane-spanning lipids are present in a wide variety of archaea, but they are rarely in bacteria. Nevertheless, the (hyper)thermophilic members of the order Thermotogales harbor tetraester, tetraether, and mixed ether/ester membrane-spanning lipids mostly composed of core lipids derived from diabolic acids, C30, C32, and C34 dicarboxylic acids with two adjacent mid-chain methyl substituents. Lipid analysis of Thermotoga maritima across growth phases revealed a decrease of the relative abundance of fatty acids together with an increase of diabolic acids with independence of growth temperature. We also identified isomers of C30 and C32 diabolic acids, i.e., dicarboxylic acids with only one methyl group at C-15. Their distribution suggests they are products of the condensation reaction but are preferably produced when the length of the acyl chains is not optimal. Compared with growth at the optimal temperature of 80°C, an increase of glycerol ether-derived lipids was observed at 55°C. Our analysis only detected diabolic acid-containing intact polar lipids with phosphoglycerol (PG) head groups. Considering these findings, we hypothesize a biosynthetic pathway for the synthesis of membrane-spanning lipids based on PG polar lipid formation, suggesting that the protein catalyzing this process is a membrane protein. We also identified, by genomic and protein domain analyses, a gene coding for a putative plasmalogen synthase homologue in T. maritima that is also present in other bacteria producing sn-1-alkyl ether lipids but not plasmalogens, suggesting it is involved in the conversion of the ester-to-ether bond in the diabolic acids bound in membrane-spanning lipids. IMPORTANCE Membrane-spanning lipids are unique compounds found in most archaeal membranes, but they are also present in specific bacterial groups like the Thermotogales. The synthesis and physiological role of membrane-spanning lipids in bacteria represent an evolutionary and biochemical open question that points to the differentiation of the membrane lipid composition. Understanding the formation of membrane-spanning lipids is crucial to solving this question and identifying the enzymatic and biochemical mechanism performing this procedure. In the present work, we found changes at the core lipid level, and we propose that the growth phase drives the biosynthesis of these lipids rather than temperature. Our results identified physiological conditions influencing the membrane-spanning lipid biosynthetic process, which can further clarify the pathway leading to the biosynthesis of these compounds.Entities:
Keywords: Thermotoga; Thermotoga maritima; biosynthesis; diabolic acid; ether lipids; growth phase; lipid biosynthesis; membrane-spanning lipids
Mesh:
Substances:
Year: 2021 PMID: 34731048 PMCID: PMC8788747 DOI: 10.1128/AEM.01763-21
Source DB: PubMed Journal: Appl Environ Microbiol ISSN: 0099-2240 Impact factor: 4.792
FIG 1Structures of membrane-spanning and non-membrane-spanning IPLs found in Thermotoga maritima. (A) General structures of non-membrane spanning IPLs. R1 and R2 are alkyl chains. (B) Examples of possible structures of membrane-spanning IPLs. (C) Some of the detected polar head groups. Glu, glucosyl; di-Glu, diglucosyl; PG, phosphoglycerol that can be attached to the structures shown in panels A and B.
Relative distribution (percentage of total) of membrane-spanning and non-membrane-spanning core lipids in T. maritima
| Lipid | Result by growth temp/growth stage | |||||
|---|---|---|---|---|---|---|
| 80°C | 55°C | |||||
| E. Exp | Exponential | Stationary | E. Exp | Exponential | Stationary | |
| Relative distribution (% of total) | ||||||
| Non-membrane-spanning | ||||||
| C14 FA | 2.2 ± 0.2 | 3.0 ± 0.5 | 4.4 ± 0.2 | 1.8 ± 0.1 | 2.9 ± 1.1 | 4.1 ± 1.6 |
| C16 FA | 42.6 ± 4.2 | 33.4 ± 5.2 | 22.4 ± 2.1 | 46.4 ± 6.5 | 45.9 ± 0.2 | 21.1 ± 2.8 |
| C18 FA | 12.8 ± 2.3 | 2.8 ± 0.4 | 1.3 ± 0.1 | 15.0 ± 5.6 | 5.6 ± 5.1 | 1.7 ± 0.1 |
| 1-O-hexadecyl glycerol (C16 FA-GE) | 1.1 ± 0.0 | 0.6 ± 0.3 | 0.3 ± 0.2 | 3.3 ± 0.5 | 3.2 ± 0.8 | 0.4 ± 0.0 |
| Membrane-spanning | ||||||
| Diabolic acids | ||||||
| 13,14-Dimethyloctacosanedioic acid (C30 DA) | 1.3 ± 0.3 | 1.6 ± 0.2 | 3.2 ± 0.6 | 0.5 ± 0.5 | 1 ± 0.2 | 2.5 ± 0.1 |
| 15,16-Dimethyltriacontanedioic acid (C32 DA) | 28.3 ± 0.4 | 42.1 ± 5.5 | 46.0 ± 6.3 | 13.4 ± 11.7 | 23 ± 2.1 | 38.8 ± 4.3 |
| 13,14-Dimethyl-28-glyceryloxyoctadecanoic acid (C30 DA-GE) | 0.5 ± 0.2 | 0.8 ± 0.1 | 1.7 ± 0.9 | 1 ± 0.6 | 1.5 ± 0.9 | 2.9 ± 0.1 |
| 15,16-Dimethyl-30-glyceryloxytriacontanoic acid (C32 DA-GE) | 6.2 ± 2.0 | 8.1 ± 0.9 | 10.8 ± 5.1 | 14.9 ± 1.5 | 12.5 ± 2.9 | 18.4 ± 0.3 |
| Monomethyl diacids | ||||||
| 15-Methylnonacosanedioic acid (C30 MM) | 0.8 ± 0.1 | 1.1 ± 0.1 | 2.2 ± 0.5 | 0.3 ± 0.3 | 0.5 ± 0 | 1.6 ± 0.1 |
| 15-Methylhentriacontanedioic acid (C32 MM) | 2.3 ± 0 | 4.4 ± 0.6 | 4.8 ± 0.8 | 0.8 ± 0.8 | 1.5 ± 0 | 3.7 ± 0.5 |
| 15-Methyl-29-glyceryloxynonadecanoic acid (C30 MM-GE) | 0.3 ± 0.1 | 0.6 ± 0.1 | 1.2 ± 0.7 | 0.6 ± 0.3 | 0.9 ± 0.6 | 2.0 ± 0.1 |
| 15-Methyl-31-glyceryloxyhentriacontanoic acid (C32 MM-GE) | 1.0 ± 0.2 | 0.9 ± 0.2 | 1.2 ± 0.6 | 1.2 ± 0.1 | 1.0 ± 0.2 | 2.1 ± 0.0 |
| Relative distribution (%, on molar basis) | ||||||
| Ethers (sum) | 4.3 | 5.0 | 6.6 | 10.4 | 9.2 | 11.5 |
| Esters (sum) | 95.7 | 95.0 | 93.4 | 89.6 | 90.8 | 88.5 |
| Membrane spanning (sum) | 41.0 | 59.4 | 70.5 | 32.0 | 41.2 | 71.2 |
| Non-membrane-spanning (sum) | 59.0 | 40.6 | 29.5 | 68.0 | 58.8 | 28.8 |
E. Exp, early exponential phase. Molar mass changes (%) of ether compounds and membrane-spanning lipids are calculated on the flame ionization detector response to the number of carbon atoms of the derivatized compounds (methyl ester and trimethylsilyl groups).
FIG 2Mass spectra of membrane-spanning monomethyl diacids methyl ester derivatives and the hydrocarbons derived from these diacids after subsequent treatment with LiAlH4 and HI/H2. (A) 15-Methylnonacosanedioic acid dimethyl ester. (B) 15-Methylhentriacontanedioic acid dimethyl ester. (C) 15-Methylnonacosane. (D) 15-Methylhentriacontane.
FIG 3Core lipid composition of T. maritima at optimal (80°C) or suboptimal (55°C) growth temperature during various growth phases. (A) Core lipid distribution of fatty acids (C14, C16, and C18 FA), diabolic acids C30 DA (13,14-dimethyloctacosanedioic acid) and C32 DA (15,16-dimethyltriacontanedioic acid), fatty acids (ether) C16 FA-GE, 1-O-hexadecyl glycerol, diabolic acids glycerol ether C30 DA-GE (13,14-dimethyl-28-glyceryloxyoctadecanoic acid), and C32 DA-GE (15,16-dimethyl-30-glyceryloxytriacontanoic acid), monomethyl diacids C30 MM (15-methylnonacosanedioic acid) and C32 MM (15-methylhentriacontanedioic acid), and monomethyl diacids glycerol ether C30 MM-GE (15-methyl-29-glyceryloxynonadecanoic acid) and C32 MM-GE (15-methyl-31-glyceryloxyhentriacontanoic acid). Bars represent the mean fractional abundance. The error indicated shows the standard deviation from three biological replicates. ANOVA significant statistical differences (P < 0.0001) between the early exponential and the stationary phases on the C16 and C32 lipids across growth phases at each temperature condition are shown. (B) The monomethyl/dimethyl diacid ratio and their glycerol ether derivatives as a function of number of carbon atoms of the diacid and growth temperature and phase. E. Exp, early exponential.
FIG 4Growth of T. maritima MSB8 in basal medium at either suboptimal (55°C) or optimal (80°C) growth temperature. Growth phases were identified based on OD600 measurements. Early exponential (0.1), exponential (0.2), and stationary (0.3 to 0.4) phases are shown. T. maritima was grown at 80°C (●) or 55°C (■).
Relative abundance and mass spectral characteristics of intact polar lipids in T. maritima
| IPL composition | Mass spectral characteristics | Relative abundance | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 80°C | 55°C | ||||||||||
| Polar head group | Core lipid | Dominant ion | Mass ( | AEC | Δmmu | E. Exp | Exp | Sta | E. Exp | Exp | Sta |
| Non-membrane-spanning (sum) | 40.6 | 42.7 | 39.6 | 62.6 | 49.8 | 39.9 | |||||
| PG | DAG, C32:0 | [M + NH4]+ | 740.543 | C38H79NO10P | 0.7 | 2.4 | 2.9 | 0.1 | 7.5 | 1.7 | 0.0 |
| PG | AEG, C30:0 | [M + H]+ | 681.506 | C36H74O9P | 0.6 | 1.0 | 0.2 | 0.3 | 0.6 | 1.9 | 0.1 |
| PG | AEG, C32:0 | [M + H]+ | 709.537 | C38H78O9P | 0.5 | 5.9 | 2.2 | 0.6 | 8.4 | 7.2 | 0.2 |
| PG | DEG, C30:0 | [M + H]+ | 667.527 | C36H76O8P | 0.3 | 0.4 | 1.1 | 2.3 | 0.0 | 0.5 | 2.9 |
| PG | DEG, C32:0 | [M + H]+ | 695.559 | C38H80O8P | 0.2 | 1.5 | 4.0 | 5.7 | 0.3 | 1.8 | 6.2 |
| diGlu | AEG, C32:0 | [M+NH4]+ | 896.667 | C47H94NO14 | 0.3 | 1.0 | 2.8 | 2.8 | 1.8 | 1.8 | 3.2 |
| diGlu | DAG, C30:0 | [M + NH4]+ | 882.615 | C45H88NO15 | 0.3 | 0.6 | 1.2 | 2.0 | 2.5 | 1.2 | 1.8 |
| diGlu | DAG, C32:0 | [M + NH4]+ | 910.646 | C47H92NO15 | 0.2 | 7.2 | 9.1 | 6.9 | 22.0 | 11.2 | 7.3 |
| diGlu | DAG, C34:0 | [M + NH4]+ | 938.678 | C49H96NO15 | 0.5 | 4.1 | 2.3 | 1.1 | 6.2 | 2.0 | 1.9 |
| diGlu | DAG, C36:0 | [M + NH4]+ | 966.709 | C51H100NO15 | 0.5 | 2.9 | 0.3 | 0.2 | 1.1 | 0.3 | 0.3 |
| Glu | DAG, C32:0 | [M + NH4]+ | 748.594 | C41H82NO10 | 0.7 | 0.3 | 0.7 | 0.5 | 0.1 | 0.1 | 0.9 |
| decanoyl-diGlu | DAG, C32:0 | [M + NH4]+ | 1,064.783 | C57H110NO16 | 0.6 | 6.8 | 6.8 | 6.4 | 7.1 | 10.0 | 5.9 |
| decanoyl-diGlu | DAG, C30:0 | [M + NH4]+ | 1,036.751 | C55H106NO16 | 0.6 | 0.5 | 1.7 | 2.3 | 0.1 | 0.8 | 2.3 |
| decanoyl-diGlu | AEG, C32:0 | [M + NH4]+ | 1,050.803 | C57H112NO15 | 0.5 | 5.6 | 6.0 | 6.4 | 5.0 | 8.7 | 5.1 |
| decanoyl-diGlu | AEG, C30:0 | [M + NH4]+ | 1,022.772 | C55H108NO15 | 1.0 | 0.3 | 1.3 | 1.9 | 0.1 | 0.6 | 1.9 |
| Membrane-spanning (sum) | 59.4 | 57.3 | 60.4 | 37.4 | 50.2 | 60.1 | |||||
| PG | Tetraether, C64:0 | [M + H]+ | 1,232.076 | C73H148O11P | 0.4 | 0.1 | 0.9 | 0.6 | 0.0 | 0.0 | 1.3 |
| PG | Triether/monoester, C64:0 | [M + NH4]+ | 1,263.082 | C73H149NO12P | 0.8 | 1.4 | 3.6 | 2.9 | 0.1 | 0.8 | 5.0 |
| PG | Diether/diester, C64:0 | [M + NH4]+ | 1,277.060 | C73H147NO13P | 0.1 | 12.0 | 9.5 | 11.9 | 1.9 | 9.1 | 10.8 |
| PG | Monoether/triester, C64:0 | [M + NH4]+ | 1,291.040 | C73H145NO14P | 0.2 | 20.3 | 11.3 | 12.6 | 12.6 | 18.8 | 12.8 |
| PG | Tetraester, C64:0 | [M + NH4]+ | 1,305.020 | C73H143NO15P | 0.6 | 10.9 | 16.3 | 8.1 | 18.9 | 10.7 | 7.7 |
| PG | Tetraether, C62:0 | [M + H]+ | 1,204.044 | C71H144O11P | 0.4 | 0.1 | 0.7 | 0.5 | 0.0 | 0.0 | 1.1 |
| PG | Triether/monoester, C62:0 | [M + NH4]+ | 1,235.051 | C71H145NO12P | 0.8 | 0.8 | 2.3 | 1.7 | 0.1 | 0.3 | 2.9 |
| PG | Diether/di ester, C62:0 | [M + NH4]+ | 1,249.028 | C71H143NO13P | 1.1 | 3.5 | 4.5 | 6.0 | 0.2 | 2.3 | 5.9 |
| PG | Monoether/triester, C62:0 | [M + NH4]+ | 1,263.008 | C71H141NO14P | 0.4 | 6.1 | 2.7 | 6.5 | 1.4 | 5.3 | 4.0 |
| PG | Tetraester, C62:0 | [M + NH4]+ | 1,276.988 | C71H139NO15P | 0.7 | 2.7 | 2.9 | 4.4 | 2.1 | 2.1 | 3.3 |
| PG | Tetraether, C60:0 | [M + H]+ | 1,204.044 | C69H140O11P | 0.7 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 |
| PG | Triether/monoester, C60:0 | [M + NH4]+ | 1,235.051 | C69H141NO12P | 0.8 | 0.1 | 0.3 | 0.2 | 0.0 | 0.0 | 0.4 |
| PG | Diether/di ester, C60:0 | [M + NH4]+ | 1,249.028 | C69H139NO13P | 1.0 | 0.1 | 0.2 | 0.3 | 0.0 | 0.1 | 0.2 |
| PG | Monoether/triester, C60:0 | [M + NH4]+ | 1,263.008 | C69H137NO14P | 0.2 | 0.4 | 0.2 | 1.1 | 0.0 | 0.3 | 0.6 |
| PG | Tetraester, C60:0 | [M + NH4]+ | 1,276.988 | C69H135NO15P | 0.3 | 0.3 | 0.3 | 1.0 | 0.0 | 0.2 | 0.6 |
| Glycerol | Diabolic acid C32:0 | [M + NH4]+ | 570.546 | C35H72NO4 | 0.3 | 0.3 | 1.0 | 1.6 | 0.0 | 0.3 | 1.9 |
| Glycerol | Diabolic acid C30:0 | [M + NH4]+ | 542.514 | C33H68NO4 | 0.1 | 0.2 | 0.5 | 0.9 | 0.0 | 0.0 | 1.2 |
Determined by HRMS analysis of extract from 80°C culture harvested at stationary phase.
Determined by ITMS analysis.
E. Exp, early exponential phase; Exp, exponential phase; Sta, stationary phase.
PG, phosphoglycerol; diGlu, diglucosyl; Glu, glucosyl.
DEG, diether glycerol; AEG, acyl ether glycerol; DAG, diacyl glycerol.
AEC, Assigned elemental composition.
mmu, milli-mass unit; Δmmu = (measured mass −calculated mass) × 1,000.
FIG 5Fluorescence microscopy of Thermotoga maritima at optimal (80°C) and suboptimal (55°C) temperature growth conditions. T. maritima cells from exponential and stationary phases at optimal temperature and exponential- and stationary-phase cells grown at suboptimal temperature are shown. Cellular profiles were imaged after the selection of the appropriate filter for each specific stain. Membrane stain was FM4-64 (red). DNA stains were membrane permeable, DAPI (blue) membrane-impermeable, and SYTOX (green). Scale bar, 5 μm. The arrows indicate coccoid cells.
Cell measurements of cellular morphological properties of T. maritima
| Temp (oC) and growth phase | Cell measurement from: | ||||
|---|---|---|---|---|---|
| DAPI | SYTOX green intensity (AU) | ||||
| Area (μm2) | Length (μm) | Circularity | Intensity (AU) | ||
| 80 | |||||
| Exponential | 1.29 ± 0.23 | 2.36 ± 0.35 | 0.53 ± 0.01 | 67.4 ± 7.8 | 42.0 ± 4.6 |
| Stationary | 0.90 ± 0.13 | 1.81 ± 0.16 | 0.60 ± 0.02 | 66.5 ± 15.6 | 39.0 ± 1.2 |
| 55 | |||||
| Exponential | 3.01 ± 0.23 | 4.14 ± 0.21 | 0.45 ± 0.03 | 65.2 ± 4.8 | 35.3 ± 6.2 |
| Stationary | 2.23 ± 0.32 | 3.52 ± 0.29 | 0.43 ± 0.03 | 80.8 ± 8.0 | 61.0 ± 16.3 |
Data represent the mean ± SD, n = 3 independent images with 100 cells measured on each image. AU, arbitrary units.
FIG 6Hypothetical biosynthetic pathway for the synthesis of diabolic acid in T. maritima. This pathway first involves the formation of a PG glycerophospholipid precursor. The genes encoding the enzymes involved in the glycerolipid backbone's biosynthesis were identified in the T. maritima genome, as indicated in the text. The final step leading to PG might be catalyzed by a potential (yet unknown) phosphatase. A membrane-spanning lipid synthase (unknown) must be responsible for joining the ω-1 carbon atoms of the FAs (C16) precursors and forming the membrane-spanning compounds. Ether lipids (sn-1 position) could be formed from PG or from membrane-spanning PG precursors by a modified plsA gene-coding enzyme.
Annotated genes in the biosynthetic pathway for glycerophospholipids in T. maritima
| Biosynthetic step | Gene name | Gene annotation in |
|---|---|---|
| Produce G3P from DHAP |
| Tmari_0376/Tmari_1438 |
| Diacylglycerol to PA |
| Tmari_0404/Tmari_0785/Tmari_0954 |
| 1st acylation-acyl phosphate |
| Tmari_0147 |
| 1st acylation-acyltransferase |
| Tmari_1453/Tmari_1289 |
| 2nd acylation |
| Tmari_1701 |
| Activation for head group synthesis |
| Tmari_1404 |
| Produces PGP |
| Tmari_1876 |
| Dephosphorylates PGP | Phosphatase | Unknown |
| Coupling of FA which are attached to one PG backbone and one DAG | Membrane-spanning lipid synthase | Unknown |
| Conversion of ester to ether bonds in the IPL compounds | Modified- | Tmari_0479 |